Boustead's surprising commitment to subscribe for the rights...

Boustead's surprising commitment to subscribe for the rights issue despite its own recapitalisation needs is noteworthy. The altered restructuring plan no longer involves a foreign pharmaceutical firm taking up a block of shares in Pharmaniaga, which could have been beneficial for the company's growth.